Literature DB >> 23872691

Fever-induced Brugada pattern: how common is it and what does it mean?

Arnon Adler1, Guy Topaz, Karin Heller, David Zeltser, Tami Ohayon, Uri Rozovski, Amir Halkin, Raphael Rosso, Shay Ben-Shachar, Charles Antzelevitch, Sami Viskin.   

Abstract

BACKGROUND: Fever is known to unmask the Brugada pattern on the electrocardiogram (ECG) and trigger ventricular arrhythmias in patients with Brugada syndrome. Genetic studies in selected cases with fever-induced Brugada pattern have identified disease-causing mutations. Thus, "fever-induced Brugada" is a recognized clinical entity. However, its prevalence has not been systematically evaluated.
OBJECTIVE: The purpose of this study was to assess the prevalence of Brugada pattern in consecutive patients with fever.
METHODS: ECGs of patients with fever admitted to the emergency department were evaluated for the presence of Brugada pattern and compared with ECGs of consecutive nonfebrile patients.
RESULTS: ECGs of 402 patients with fever and 909 without were evaluated. Type I Brugada pattern was 20 times more common in the febrile group than in the afebrile group (2% vs. 0.1%, respectively, P = .0001). All patients with fever-induced type I Brugada pattern were asymptomatic and remained so during 30 months of follow-up.
CONCLUSION: Type I Brugada pattern is definitively more common among patients with fever, suggesting that asymptomatic Brugada syndrome is more prevalent than previously estimated.
© 2013 Heart Rhythm Society. All rights reserved.

Entities:  

Keywords:  AIDS; Brugada syndrome; ECG; Fever; Ventricular fibrillation; acquired immunodeficiency syndrome; electrocardiogram

Mesh:

Year:  2013        PMID: 23872691      PMCID: PMC3832740          DOI: 10.1016/j.hrthm.2013.07.030

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  40 in total

1.  Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms.

Authors:  W Shimizu; K Matsuo; M Takagi; Y Tanabe; T Aiba; A Taguchi; K Suyama; T Kurita; N Aihara; S Kamakura
Journal:  J Cardiovasc Electrophysiol       Date:  2000-04

2.  Transient ST segment elevation in right precordial leads induced by psychotropic drugs: relationship to the Brugada syndrome.

Authors:  F Rouleau; P Asfar; S Boulet; L Dube; J M Dupuis; P Alquier; J Victor
Journal:  J Cardiovasc Electrophysiol       Date:  2001-01

3.  MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis.

Authors:  G W Abbott; M H Butler; S Bendahhou; M C Dalakas; L J Ptacek; S A Goldstein
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

4.  Frequency of Brugada type ECG pattern in male subjects with fever.

Authors:  Okan Erdogan; Burak Hunuk
Journal:  Int J Cardiol       Date:  2012-09-27       Impact factor: 4.164

5.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.

Authors:  R Dumaine; J A Towbin; P Brugada; M Vatta; D V Nesterenko; V V Nesterenko; J Brugada; R Brugada; C Antzelevitch
Journal:  Circ Res       Date:  1999-10-29       Impact factor: 17.367

6.  Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Authors:  Ping Yang; Hideaki Kanki; Benoit Drolet; Tao Yang; Jian Wei; Prakash C Viswanathan; Stefan H Hohnloser; Wataru Shimizu; Peter J Schwartz; Marshall Stanton; Katherine T Murray; Kris Norris; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

7.  Sudden cardiac arrest associated with use of a non-cardiac drug that reduces cardiac excitability: evidence from bench, bedside, and community.

Authors:  Abdennasser Bardai; Ahmad S Amin; Marieke T Blom; Connie R Bezzina; Jocelyn Berdowski; Pim N J Langendijk; Leander Beekman; Christine A Klemens; Patrick C Souverein; Rudolph W Koster; Anthonius de Boer; Hanno L Tan
Journal:  Eur Heart J       Date:  2013-02-20       Impact factor: 29.983

8.  Fever unmasking the Brugada syndrome.

Authors:  José Manuel Porres; Josep Brugada; Vicente Urbistondo; Francisco García; Karlos Reviejo; Pilar Marco
Journal:  Pacing Clin Electrophysiol       Date:  2002-11       Impact factor: 1.976

9.  Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome.

Authors:  Hiroshi Morita; Satoshi Nagase; Kengo Kusano; Tohru Ohe
Journal:  J Cardiovasc Electrophysiol       Date:  2002-08

10.  p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.

Authors:  Lucía Núñez; Adriana Barana; Irene Amorós; Marta González de la Fuente; Pablo Dolz-Gaitón; Ricardo Gómez; Isabel Rodríguez-García; Ignacio Mosquera; Lorenzo Monserrat; Eva Delpón; Ricardo Caballero; Alfonso Castro-Beiras; Juan Tamargo
Journal:  Heart Rhythm       Date:  2012-10-18       Impact factor: 6.343

View more
  35 in total

1.  Coexistence of atrioventricular accessory pathways and drug-induced type 1 Brugada pattern.

Authors:  Can Hasdemir; Jimmy Jyh-Ming Juang; Sedat Kose; Umut Kocabas; Mehmet N Orman; Serdar Payzin; Hatice Sahin; Candan Celen; Emin E Ozcan; Ching-Yu Julius Chen; Ramazan Gunduz; Oguzhan E Turan; Oktay Senol; Elena Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-07-16       Impact factor: 1.976

2.  Fever-Induced Brugada Syndrome Is More Common Than Previously Suspected: A Cross-Sectional Study from an Endemic Area.

Authors:  Pattara Rattanawong; Wasawat Vutthikraivit; Attawit Charoensri; Tanawat Jongraksak; Awapa Prombandankul; Napatt Kanjanahattakij; Sakda Rungaramsin; Treechada Wisaratapong; Tachapong Ngarmukos
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-07-14       Impact factor: 1.468

3.  Discovering Brugada syndrome during preoperative evaluation.

Authors:  Pattara Rattanawong; Tachapong Ngarmukos; Treechada Wisaratapong
Journal:  J Anesth       Date:  2014-10-28       Impact factor: 2.078

Review 4.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

5.  Reappraisal of the Worldwide Prevalence of Brugada Syndrome and Brugada Phenotype: From the Old to the New Diagnostic Criteria.

Authors:  Fa-Po Chung; Chin-Yu Lin; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

Review 6.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

Review 7.  Mechanisms and models of cardiac sodium channel inactivation.

Authors:  Kathryn E Mangold; Brittany D Brumback; Paweorn Angsutararux; Taylor L Voelker; Wandi Zhu; Po Wei Kang; Jonathan D Moreno; Jonathan R Silva
Journal:  Channels (Austin)       Date:  2017-09-21       Impact factor: 2.581

8.  Brugada Syndrome Unmasked by Heat Exhaustion.

Authors:  Uğur Canpolat; Yesim Bayazit; Kudret Aytemir
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-28       Impact factor: 1.468

9.  Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome.

Authors:  Bence Patocskai; Charles Antzelevitch
Journal:  Expert Opin Orphan Drugs       Date:  2015-05-13       Impact factor: 0.694

Review 10.  Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Authors:  Charles Antzelevitch; Bence Patocskai
Journal:  Curr Probl Cardiol       Date:  2015-06-11       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.